Institute of Physiology, Zurich Center for Integrative Human Physiology, Switzerland.
Ann Endocrinol (Paris). 2012 Apr;73(2):128-9. doi: 10.1016/j.ando.2012.03.032. Epub 2012 Apr 13.
Nephrogenic diabetes insipidus (NDI) is caused by an improper response of the kidney to the antidiuretic hormone arginine vasopressin (AVP), leading to a decreased ability to concentrate urine which results in polyuria and polydipsia. The clinical diagnosis of NDI relies on demonstration of subnormal ability to concentrate urine despite the presence of AVP. NDI is most commonly acquired, secondary to kidney disorders, electrolyte imbalance and various drugs. Congenital forms of NDI are rare, and most commonly inherited in a X-linked manner with mutations of the AVP receptor type 2 (AVPR2). Mutations of the water channel aquaporin-2 (AQP2) can be detected in autosomal recessive or dominant forms of NDI. Management of NDI should focus on free access to drinking water and reduction of polyuria.
肾源性尿崩症(NDI)是由肾脏对抗利尿激素精氨酸加压素(AVP)的反应不当引起的,导致尿液浓缩能力下降,从而导致多尿和多饮。NDI 的临床诊断依赖于尽管存在 AVP,但仍显示出尿液浓缩能力异常的证据。NDI 最常见于获得性疾病,继发于肾脏疾病、电解质失衡和各种药物。先天性 NDI 很少见,最常见的是 X 连锁遗传,突变位于 AVP 受体 2 型(AVPR2)。常染色体隐性或显性遗传的 NDI 中可检测到水通道蛋白 2(AQP2)的突变。NDI 的治疗应侧重于自由饮水和减少多尿。